within Pharmacolibrary.Drugs.N_NervousSystem.N05B_Anxiolytics.N05BA01_Diazepam;

model Diazepam
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.93,
    Cl = 2.7777777777777776e-07,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.1,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0006333333333333333,
    Tlag = 600,
    Vdp = 0.215,
    k12 = 1.2166666666666667e-05,
    k21 = 1.2166666666666667e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Diazepam</td></tr><tr><td>ATC code:</td><td>N05BA01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>100</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.0</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Diazepam is a long-acting benzodiazepine used for the treatment of anxiety disorders, muscle spasms, seizures, and alcohol withdrawal, and as a premedication for anesthesia. It enhances the effect of gamma-aminobutyric acid (GABA) at the GABAA receptor. Diazepam is approved and widely used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Wang, LL, et al., &amp; Yun, KM (2020). An Experimental Pharmacokinetics Study of Diazepam and Its Metabolites in Oral Fluid of Chinese Population. <i>Journal of analytical toxicology</i> 44(4) 348–353. DOI:<a href=\"https://doi.org/10.1093/jat/bkz101\">10.1093/jat/bkz101</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31965188/\">https://pubmed.ncbi.nlm.nih.gov/31965188</a></p></li><li><p>Wang, LL, et al., &amp; Yun, KM (2020). Study on the Pharmacokinetics of Diazepam and Its Metabolites in Blood of Chinese People. <i>European journal of drug metabolism and pharmacokinetics</i> 45(4) 477–485. DOI:<a href=\"https://doi.org/10.1007/s13318-020-00614-8\">10.1007/s13318-020-00614-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32219697/\">https://pubmed.ncbi.nlm.nih.gov/32219697</a></p></li><li><p>Khalid, S, et al., &amp; Alqahtani, F (2021). A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications. <i>Pharmaceutics</i> 13(9) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics13091480\">10.3390/pharmaceutics13091480</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34575556/\">https://pubmed.ncbi.nlm.nih.gov/34575556</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N05BA01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Diazepam;
